Jennifer B. Damico - 22 Feb 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
SVP & Controller
Signature
Susan E. Grant, by power of atty., for Jennifer B. Damico
Issuer symbol
PFE
Transactions as of
22 Feb 2023
Net transactions value
-$29,611
Form type
4
Filing time
24 Feb 2023, 19:14:17 UTC
Previous filing
21 Feb 2023
Next filing
17 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $315,458 +10,456 +94% $30.17 21,584 22 Feb 2023 Direct F1
transaction PFE Common Stock Tax liability $66,918 -1,579 -7.3% $42.38 20,005 22 Feb 2023 Direct F2
transaction PFE Common Stock Tax liability $278,150 -6,365 -32% $43.70 13,640 22 Feb 2023 Direct F3, F4
transaction PFE Common Stock Award $0 +3,103 +23% $0.000000 16,743 23 Feb 2023 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -10,456 -100% $0.000000* 0 22 Feb 2023 Common Stock 10,456 $30.17 Direct
transaction PFE Stock Appreciation Rights Award $0 +12,169 $0.000000 12,169 23 Feb 2023 Common Stock 12,169 $42.30 Direct F6
transaction PFE Stock Appreciation Rights Award $0 +10,591 $0.000000 10,591 23 Feb 2023 Common Stock 10,591 $42.30 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F5 The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F6 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
F7 The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.